Literature DB >> 22145515

Cauda equina involvement in acute myeloid leukemia relapse.

Jitsuda Buakhao1, Amarate Tansawet.   

Abstract

Although central nervous system (CNS) involvement in acute myeloid leukemia has been described in about 2 to 4%, it still represents a major therapeutic problem, particularly cauda eqina involvement that is clinically significant and unusual. Here, a 22-year-old man, with underlying AML (M2-Subtype, FAB classification) and cytogenetic analysis resulted in 45, x, -y, t(8;21) (q22;q22)[15] whose presenting symptoms of low back pain and incontinence, 10 months after first remission, was reported. This was followed by peripheral and bone marrow relapse. The magnetic resonance image (MRI) findings revealed leukemic infiltration at S1-S5 of the spinal cord canal with associated soft tissue component at presacral area encasing bilateral S1-S5 exiting root with heterogeneous enhancement in bone marrow of S2-S4. The therapeutic and prognosis implications of spinal cord involvement by leukemia were discussed. Because of severe morbidity, the patient developed bone marrow failure and died from sepsis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22145515

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  3 in total

1.  Development of acute promyelocytic leukemia in a patient with tetraplegia while in inpatient rehabilitation: A case report.

Authors:  Christopher A Beal; Michael C Krouse; Jeffrey T Tubbs
Journal:  J Spinal Cord Med       Date:  2017-09-20       Impact factor: 1.985

Review 2.  Central nervous system niche involvement in the leukemia.

Authors:  N Heidari; N Saki; L De Filippis; M Shahjahani; A Teimouri; A Ahmadzadeh
Journal:  Clin Transl Oncol       Date:  2015-08-05       Impact factor: 3.405

3.  Pseudo-Guillain-Barré syndrome masking acute myeloid leukemia relapse: Brief report and review.

Authors:  Fadi El Karak; Elie El Rassy; Samer Tabchi; Eliane Chouery; Andre Megarbane; Joseph Kattan
Journal:  Leuk Res Rep       Date:  2015-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.